Contribution of vesicular and cytosolic dopamine to the increased striatal dopamine efflux elicited by intrastriatal injection of SKF38393

European Journal of Pharmacology

Volumn 624, Issue 1-3, 2009, Pages 10-15

  Saigusa, Tadashi ^a   Aono, Yuri ^a   Sekino, Reiko ^a   Uchida, Takuya ^a   Takada, Koji ^a   Oi, Yoshiyuki ^a   Koshikawa, Noriaki ^a   Cools, Alexander R ^b  

^a NIHON UNIVERSITY   (Japan)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

(Rat); Alpha methyl para tyrosine; Dopamine; Microdialysis; Reserpine; SKF38393; Striatum

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DOPAMINE; DOPAMINE 1 RECEPTOR; METIROSINE; RESERPINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL VACUOLE; CONTROLLED STUDY; CORPUS STRIATUM; CYTOSOL; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DOPAMINE UPTAKE; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ALPHA-METHYLTYROSINE; ANIMALS; CYTOSOL; DOPAMINE; DOPAMINE AGONISTS; INJECTIONS, INTRAVENTRICULAR; MALE; NEOSTRIATUM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RESERPINE; TRANSPORT VESICLES;

EID: 70350705701     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.10.005     Document Type: Article

References (39)

1. Ajima A., Yamaguchi T., and Kato T. Modulation of acetylcholine release by D1, D2 dopamine receptors in rat striatum under freely moving conditions. Brain Res. 518 (1990) 193-198
2. Arnsten A. Stimulants: therapeutic actions in ADHD. Neuropsychpharmacology 31 (2009) 2371-2386
3. Benveniste H., Hansen A.J., and Ottosen N.S. Determination of brain interstitial concentrations by microdialysis. J. Neurochem. 52 (1989) 1741-1750
4. Besson M.J., Cheramy A., Feltz P., and Glowinski J. Release of newly synthesized dopamine from dopamine containing terminals in the striatum of the rat. Proc. Natl. Acad. Sci. U. S. A. 62 (1969) 741-748
5. Brooderson R.J., White F.J., and Galloway M.P. Inhibition of dopamine synthesis in striatal slices by the D1 agonist SKF 38393 is not mediated by D1 dopamine receptors. Synapse 6 (1990) 395-397
6. Butcher S.P., Fairbrother I.S., Kelly J.S., and Arbuthnott G.W. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study. J. Neurochem. 50 (1988) 346-355
7. Cadoni C., Pinna A., Russi G., Consolo S., and Di Chiara G. Role of vesicular dopamine in the in vivo stimulation of striatal dopamine transmission by amphetamine: evidence from microdialysis and Fos immunohistochemistry. Neuroscience 65 (1995) 1027-1039
8. Carboni E., Imperato A., Perezzani L., and Di Chiara G. Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience 28 (1989) 653-661
9. Floor E., Leventhal P.S., Wang Y., Meng L., and Chen W. Dynamic storage of dopamine in rat brain synaptic vesicles in vitro. J. Neurochem. 64 (1995) 689-699
10. Fusa K., Saigusa T., Koshikawa N., and Cools A.R. Tyrosine-induced release of dopamine is under inhibitory control of presynaptic dopamine D2 and, probably, D3 receptors in the dorsal striatum, but not in the nucleus accumbens. Eur. J. Pharmacol. 448 (2002) 143-150
11. Fusa K., Takahashi I., Watanabe S., Aono Y., Ikeda H., Saigusa T., Nagase H., Suzuki T., Koshikawa N., and Cools A.R. The non-peptidic delta opioid receptor agonist TAN-67 enhances dopamine efflux in the nucleus accumbens of freely moving rats via a mechanism that involves both glutamate and free radicals. Neuroscience 130 (2005) 743-753
12. Gropetti A., Algeri S., Cattabeni F., Di Giulio A.M., Galli C.L., Ponzio F., and Spano P.F. Changes in specific activity of dopamine metabolites as evidence of a multiple compartmentalization of dopamine in striatal neurons. J. Neurochem. 28 (1977) 191-197
13. Habuchi Y., Tanaka H., Nishio M., Yamamoto T., Komori T., Morikawa J., and Yoshimura M. Dopamine stimulation of cardiac beta-adrenoceptors: the involvement of sympathetic amine transporters and the effect of SKF38393. Br. J. Pharmacol. 122 (1997) 1669-1678
14. Hardy S.E. Methylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults. Am. J. Geriatr. Pharmacother. 7 (2009) 34-59
15. Javoy F., and Glowinski J. Dynamic characteristic of the 'functional compartment' of dopamine in dopaminergic terminals of the rat striatum. J. Neurochem. 18 (1971) 1305-1311
16. Kuczenski R. Differential effects of reserpine and tetrabenazine on rat striatal synaptosomal dopamine biosynthesis and synaptosomal dopamine pools. J. Pharmacol. Exp. Ther. 201 (1977) 357-367
17. Kurata K., and Shibata R. Effects of D1 and D2 antagonists on the transient increase of dopamine release by dopamine agonists by means of brain dialysis. Neurosci. Lett. 133 (1991) 77-80
18. Lindefors N., Amberg G., and Ungerstedt U. Intracerebral microdialysis: I. Experimental studies of diffusion kinetics. J. Pharmacol. Methods 22 (1989) 141-156
19. Nutt J.G., Carter J.H., and Sexton G.J. The dopamine transporter: importance in Parkinson's disease. Ann. Neurol. 55 (2004) 766-773
20. Østergaard K., Schou J.P., and Zimmer J. Rat ventral mesencephalon grown as organotypic slice cultures and co-cultured with striatum, hippocampus, and cerebellum. Exp. Brain Res. 82 (1990) 547-565
21. Papeschi R. Behavioral and biochemical interaction between AMT and (+)-amphetamine: relevance to the identification of the functional pool of brain catecholamines. Psychopharmacologia (Berl.) 45 (1975) 21-28
22. Parker G., and Brotchie H. Do the old psychostimulant drugs have a role in managing treatment-resistant depression?. Acta Psychiatr. Scand. (2009) July 9 (Electronic publication ahead of print)
23. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. 4th edn. (1998), Academic Press, New York
24. Peter D., Jimenez J., Liu Y., Kim J., and Edwards R.H. The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors. J. Biol. Chem. 269 (1994) 7231-7237
25. Randrup A., and Munkvad I. Role of catecholamines in the amphetamine excitatory response. Nature 211 (1966) 540
26. Ribeiro M.J., Vidailhet M., Loc'h C., Dupel C., Nguyen J.P., Ponchant M., Dollé F., Peschanski M., Hantraye P., Cesaro P., Samson Y., and Remy P. Dopaminergic function and dopamine transporter binding assessed with positron emission tomography in Parkinson disease. Arch. Neurol. 59 (2002) 580-586
27. Saigusa T., Takada K., Baker S.C., Kumar R., and Stephenson J.D. Dopamine efflux in the rat nucleus accumbens evoked by dopamine receptor stimulation in the entorhinal cortex is modulated by oestradiol and progesterone. Synapse 25 (1997) 37-43
28. Saigusa T., Tuinstra T., Koshikawa N., and Cools A.R. High and low responders to novelty: effects of a catecholamine synthesis inhibitor on novelty-induced changes in behavior and release of accumbal dopamine. Neuroscience 88 (1999) 1153-1163
29. Saigusa T., Fusa K., Okutsu H., and Koshikawa N. Monitoring of extracellular dopamine levels in the dorsal striatum and the nucleus accumbens with 5-minute on-line microdialysis in freely moving rats. J. Oral Sci. 43 (2001) 129-134
30. B receptors in the endomorphin-1-, but not endomorphin-2-, induced dopamine efflux in the nucleus accumbens of freely moving rats. Eur. J. Pharmacol. 581 (2008) 276-282
31. Scheel-Krüger J. Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain. Eur. J. Pharmacol. 14 (1971) 47-59
32. Sulzer D., Chen T.K., Lau Y.Y., Kristensen H., Rayport S., and Ewing A. Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J. Neurosci. 15 (1995) 4102-4108
33. Sulzer D., St Remy C., and Rayport S. Reserpine inhibits amphetamine action in ventral midbrain culture. Mol. Pharmacol. 49 (1996) 338-442
34. Tomiyama K., Noguchi M., Koshikawa N., and Kobayashi M. YM-09151-2 but not l-suspired induces transient dopamine release in rat striatum via a tetrodotoxin-insensitive mechanism. J. Neurochem. 60 (1993) 1690-1695
35. Tomiyama K., Koshikawa N., Funada K., Oka K., and Kobayashi M. In vivo microdialysis evidence for transient dopamine release by benzazepines in rat striatum. J. Neurochem. 65 (1995) 2790-2795
36. Watanabe S., Aono Y., Fusa K., Takada K., Saigusa T., Koshikawa N., and Cools A.R. Contribution of vesicular and cytosolic dopamine to the increased striatal dopamine efflux elicited by intrastriatal injection of dexamphetamine. Neuroscience 136 (2005) 251-257
37. Weissman A., Koe B.K., and Tenen S.S. Antiamphetamine effects following inhibition of tyrosine hydroxylase. J. Pharmacol. Exp. Ther. 151 (1966) 339-352
38. Yavich L. Two simultaneously working storage pools of dopamine in mouse caudate and nucleus accumbens. Br. J. Pharmacol. 119 (1996) 869-876
39. Zackheim J.A., and Abercrombie E.D. Decreased striatal dopamine efflux after intrastriatal application of benzazepine-class D1 agonists is not mediated via dopamine receptors. Brain Res. Bull. 54 (2001) 603-607